What is the appropriate management of a high‑risk gastrointestinal bleed?

High-Risk GI Bleed Management

For patients with high-risk nonvariceal upper GI bleeding, perform endoscopic hemostatic therapy with thermocoagulation or sclerosant injection (never epinephrine alone), followed by IV PPI loading dose and continuous infusion for 72 hours, then hospitalize for at least 72 hours post-hemostasis. 1

Initial Resuscitation & Risk Stratification

• Transfusion threshold: Use restrictive red blood cell transfusion at hemoglobin 7-8 g/dL (unless cardiovascular disease present) 23
• IV fluid resuscitation: Initiate as needed based on hemodynamic status
• Identify high-risk stigmata requiring intervention: active bleeding (spurting/oozing) or visible vessel in ulcer bed 1

Pre-Endoscopic Management

Pharmacologic preparation:

• Erythromycin infusion before endoscopy to improve visualization 45
• PPI therapy should be started pre-endoscopy 3
• DO NOT use: H2-receptor antagonists, somatostatin, or octreotide for ulcer bleeding 1
• DO NOT use tranexamic acid 4

Special population - Cirrhosis with suspected variceal bleeding:

• Start prophylactic antibiotics immediately (before endoscopy) 23
• Start vasoactive medications immediately 23

Timing: Perform endoscopy within 24 hours of presentation 15

Endoscopic Hemostasis

For high-risk stigmata (active bleeding or visible vessel):

Primary recommended methods (strong recommendation):

• Thermocoagulation (bipolar electrocoagulation, heater probe) 15
• Sclerosant injection (absolute ethanol) 15
• No single thermal method is superior to another 1

Alternative methods (conditional recommendation):

• Through-the-scope clips 15
• Argon plasma coagulation 5

Critical caveat: Epinephrine injection alone is suboptimal and must be combined with another method 11 - this is a common pitfall to avoid.

Rescue therapies when conventional methods fail:

• TC-325 hemostatic powder spray: Use as temporizing therapy when conventional therapies unavailable or fail, but NOT as single therapeutic strategy 115
• Over-the-scope clips (OTSCs): Consider for recurrent ulcer bleeding after previous successful hemostasis 45

DO NOT perform routine second-look endoscopy 11

Post-Endoscopic Pharmacologic Management

PPI regimen (strong recommendation, moderate-quality evidence):

• IV loading dose followed by continuous IV infusion for 72 hours 115
• Then switch to twice-daily oral PPI for 14 days, followed by once daily 11
• Continue single daily-dose oral PPI long-term as dictated by underlying cause 1

This intensive PPI regimen applies specifically to patients with high-risk stigmata who underwent successful endoscopic therapy.

Hospitalization & Monitoring

• Hospitalize for at least 72 hours after endoscopic hemostasis for high-risk stigmata 11
• Early enteral feeding: Can feed within 24 hours for low-risk patients; initiate early feeding for all UGIB patients 14

Management of Rebleeding

If rebleeding occurs:

1. Repeat endoscopic therapy is generally recommended as first-line approach 115
2. If endoscopic therapy fails:
   • Interventional radiology with transcatheter embolization is suggested as alternative to surgery (where available) 115
   • Surgical consultation for patients where endoscopic therapy has failed 11

Secondary Prevention

Helicobacter pylori management:

• Test all patients with bleeding peptic ulcers for H. pylori 11
• Provide eradication therapy if present with confirmation of eradication 1
• Repeat negative tests obtained during acute setting, as false negatives occur 1

Antiplatelet/anticoagulant considerations:

• For patients requiring NSAIDs after previous ulcer bleeding: Use PPI plus COX-2 inhibitor combination (not COX-2 inhibitor alone) 1
• For patients on single or dual antiplatelet therapy: Use PPI therapy 1
• For patients on anticoagulation (warfarin, DOACs): Use PPI therapy 1
• Restart aspirin when cardiovascular risk outweighs bleeding risk 1

Key Pitfalls to Avoid

1. Never use epinephrine injection alone - always combine with thermal or mechanical method
2. Don't perform routine second-look endoscopy - only for rebleeding
3. Don't use H2-receptor antagonists for acute ulcer bleeding
4. Don't discharge high-risk patients early - minimum 72-hour observation required
5. Don't forget H. pylori testing and eradication - critical for preventing recurrence